Allgemein- und Viszeralchirurgie up2date, Table of Contents Allgemein- und Viszeralchirurgie up2date 2020; 14(02): 203-217DOI: 10.1055/a-1120-0454 Leber, Galle, Pankreas, Milz Georg Thieme Verlag KG Stuttgart · New York Periampulläre Tumoren: Therapie und Prognose Torsten Herzog , Waldemar Uhl Recommend Article Abstract Buy Article All articles of this category Periampulläre Tumoren umfassen gut- und bösartige Neubildungen des Pankreaskopfes, des distalen Gallengangs, des Duodenums und der Ampulla Vateri. Während der 1. Teil des Artikels die Klassifikation dieser Tumoren, die Anatomie, die Symptomatik und das diagnostische Vorgehen beschreibt [1], widmet sich dieser 2. Teil der Therapie sowie der Prognose. Schlüsselwörter SchlüsselwörterTumorchirurgie - distales Gallengangkarzinom - Karzinom der Ampulla Vateri - Duodenalkarzinom - Duodenaladenom Full Text References Literatur 1 Herzog T, Uhl W. Periampulläre Tumoren – Teil 1: Epidemiologie, Einteilung und Diagnostik. Allg Viszeralchir up2date 2019; 14: 187-200 2 Ochiai Y, Kato M, Kiguchi Y. et al. Current status and challenges of endoscopic treatments for duodenal tumors. Digestion 2019; 99: 21-26 3 Hara Y, Goda K, Dobashi A. et al. Short-and long-term outcomes of endoscopically treated superficial non-ampullary duodenal epithelial tumors. World J Gastroenterol 2019; 25: 707-718 4 Yamamoto K, Itoi T, Sofuni A. et al. Expanding the indication of endoscopic papillectomy for T1a ampullary carcinoma. Digest Endosc 2019; 31: 188-196 doi:10.1111/den.13265 5 Attila T, Parlak E, Alper E. et al. Endoscopic papillectomy of benign ampullary lesions: Outcomes from a multicenter study. Turk J Gastroenterol 2018; 29: 325-334 doi:10.5152/tjg.2018.17378 6 Sakai A, Tsujimae M, Masuda A. et al. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy. World J Gastroenterol 2019; 25: 1387-1397 7 Herzog T. Prävention und Therapie biliärer Komplikationen bei pankreaschirurgischen Eingriffen [Kumulative Habilitationsschrift]. Bochum: Ruhr Universität Bochum; 2016 8 Wierick A, Distler M, Weitz J. et al. Tumoren der Papille und des Duodenums. Allg Viszeralchir up2date 2016; 10: 183-198 doi:10.1055/s-0042-104626 9 Parc Y, Mabrut JY, Shields C. et al. Surgical management of the duodenal manifestations of familial adenomatous polyposis. Br J Surg 2011; 98: 480-484 doi:10.1002/bjs.7374 10 Sarmiento JM, Thompson GB, Nagorney DM. et al. Pancreas-sparing Duodenectomy for Duodenal Polyposis. Arch Surg 2002; 137: 557-563 11 Belyaev O, Uhl W. Pankreaskarzinom – Chirurgie im Wandel der multimodalen Therapiemöglichkeiten. Allg Viszeralchir up2date 2019; 13: 511-530 doi:10.1055/a-1034-3032 12 Strijker M, Belkouz A, van der Geest LG. et al. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol 2019; 58: 1048-1055 13 Al-Jumayli M, Batool A, Middiniti A. et al. Clinical outcome of ampullary carcinoma: single cancer center experience. J Oncol 2019; 2019: 3293509 doi:10.1155/2019/3293509 14 Bowitz Lothe IM, Kleive D, Pomianowska E. et al. Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy. Pancreatology 2019; 19: 316-324 15 Zimmermann C, Wolk S, Aust DE. et al. The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma. Sci Rep 2019; 9: 12676 doi:10.1038/s41598-019-49179-w 16 Meijer LL, Alberga AJ, de Bakker JK. et al. Outcomes and treatment options for duodenal adenocarcinoma: a systematic review and meta-analysis. Ann Surg Oncol 2018; 25: 2681-2692 17 RKI. Krebs in Deutschland 2015/2016. Im Internet: https://www.rki.de/DE/Content/Gesundheitsmonitoring/Krebsregisterdaten/krebs_node.html Stand: 23.12.2019 18 Ecker BL, Vollmer CM, Behrman SW. et al. Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma. JAMA Surg 2019; 19 Tsen A, Barbara M, Rosenkranz L. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology 2018; 18: 862-867 doi:10.1016/j.pan.2018.09.004 20 Trape J, Filella X, Alsina-Donadeu M. et al. Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 2011; 49: 1605-1620 doi:10.1515/CCLM.2011.694 21 Belyaev O, Munding J, Tannapfel A. et al. False-positive PET/CT after cyanoacrylate sealing of a pancreaticojejunostomy. J Gastrointest Surg 2015; 19: 984-985 doi:10.1007/s11605-015-2780-9 22 Regalla DKR, Jacob R, Manne A. et al. Therapeutic options for ampullary carcinomas. A review. Oncol Rev 2019; 13: 440 doi:10.4081/oncol.2019.440 23 Nappo G, Gentile D, Galvanin J. et al. Trans-duodenal ampullectomy for ampullary neoplasms: early and long-term outcomes in 36 consecutive patients. Surg Endosc 2019; 24 Weitz J, Rahbari N, Koch M. et al. The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg 2010; 210: e1-e4 doi:10.1016/j.jamcollsurg.2009.10.019 25 Tol JA, Gouma DJ, Bassi C. et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 2014; 156: 591-600 doi:10.1016/j.surg.2014.06.016 26 Uhl W, Sülberg D. Pyloruserhaltende Duodenohemipankreatektomie nach Traverso-Longmire mit T-Drainage (pp-Whipple). Im Internet: https://www.webop.de/Allgemein-und-Viszeralchirurgie/Pankreas-und-Milz/Pyloruserhaltende-Duodenohemipankreatektomie-nach-Traverso-Longmire-mit-T-Drainage-pp-Whipple Stand: 21.02.2020 27 Krautz C, Nimptsch U, Weber GF. et al. Effect of hospital volume on in-hospital morbidity and mortality following pancreatic surgery in Germany. Ann Surg 2018; 267: 411-417 doi:10.1097/SLA0000000000002248 28 Limongelli P, Khorsandi SE, Pai M. et al. Management of delayed postoperative hemorrhage after pancreaticoduodenectomy: a meta-analysis. Arch Surg 2008; 143: 1001-1007 doi:10.1001/archsurg.143.10.1001 discussion 1007 29 Popivanov GI, Mutafchiyski VM, Cirocchi R. et al. Endoluminal negative pressure therapy in colorectal anastomotic leaks. Colorect Dis 2019; Stand: 21.02.2020; 30 Bassi C, Dervenis C, Butturini G. et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138: 8-13 doi:10.1016/j.surg.2005.05.001 31 Koch M, Garden OJ, Padbury R. et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 2011; 149: 680-688 doi:10.1016/j.surg.2010.12.002 32 Khalsa BS, Imagawa DK, Chen JI. et al. Evolution in the treatment of delayed postpancreatectomy hemorrhage: surgery to interventional radiology. Pancreas 2015; 44: 953-958 doi:10.1097/MPA0000000000000347 33 Ecker BL, McMillan MT, Datta J. et al. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Cancer 2017; 123: 967-976 doi:10.1002/cncr.30439 34 Primrose JN, Fox RP, Palmer DH. et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 2019; 20: 663-673 doi:10.1016/S1470-2045(18)30915-X 35 Onkologie DGfHuM. Karzinome der Gallengänge und Gallenblase-Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen. Im Internet: https://www.onkopedia.com/de/onkopedia/guidelines/maligne-biliaere-tumoren/@@guideline/html/index.html Stand: 17.09.2019 36 Ye X, Zhang G, Chen H. et al. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018; 13: e0200204 doi:10.1371/journal.pone.0200204 37 Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 2015; 220: 530-536 doi:10.1016/j.jamcollsurg.2014.12.031 38 Petrova E, Ruckert F, Zach S. et al. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study. Langenbecks Arch Surg 2017; 402: 831-840 doi:10.1007/s00423-017-1590-9 39 Zhou Y, Liu S, Wu L. et al. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg 2017; 40: 129-138 doi:10.1016/j.asjsur.2015.07.002 40 Courtin-Tanguy L, Turrini O, Bergeat D. et al. Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma. HPB (Oxford) 2018; 20: 405-410 doi:10.1016/j.hpb.2017.10.016 41 Li HB, Zhao FQ, Zhou J. Prognostic nomogram for disease-specific survival in patients with non-metastatic ampullary carcinoma after surgery. Ann Surg Oncol 2019; 26: 1079-1085 42 Marabelle A, Le DT, Ascierto PA. et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 2020; 38: 1-10 doi:10.1200/JCO.19.02105
